Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[cell type]	Characteristics[cell line]	Characteristics[developmental stage]	Characteristics[disease]	Characteristics[ancestry category]	Characteristics[sex]	Characteristics[age]	Characteristics[biological replicate]	Material Type	assay name	technology type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[cleavage agent details]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	Factor Value[disease]
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-1	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 1	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F1.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F1.raw	1	1	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-2	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 2	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F2.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F2.raw	1	2	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-3	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 3	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F3.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F3.raw	1	3	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-4	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 4	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F4.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F4.raw	1	4	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-5	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 5	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F5.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F5.raw	1	5	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-6	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 6	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F6.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F6.raw	1	6	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-7	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 7	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F7.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F7.raw	1	7	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-8	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 8	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F8.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F8.raw	1	8	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-9	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 9	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F9.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F9.raw	1	9	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-10	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 10	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F10.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F10.raw	1	10	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-11	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 11	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F11.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F11.raw	1	11	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-12	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 12	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F12.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F12.raw	1	12	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-13	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 13	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F13.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F13.raw	1	13	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-14	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 14	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F14.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F14.raw	1	14	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-15	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 15	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F15.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F15.raw	1	15	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-16	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 16	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F16.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F16.raw	1	16	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-17	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 17	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F17.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F17.raw	1	17	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-18	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 18	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F18.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F18.raw	1	18	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-19	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 19	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F19.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F19.raw	1	19	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-20	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 20	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F20.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F20.raw	1	20	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-21	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 21	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F21.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F21.raw	1	21	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-22	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 22	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F22.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F22.raw	1	22	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-23	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 23	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F23.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F23.raw	1	23	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT126	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT127	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT128	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT129	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT130	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
PXD030881-Sample-24	Homo sapiens	Breast cancer cell line	not available	not available	not available	breast cancer	not available	not available	not available	1	organism part	run 24	proteomic profiling by mass spectrometry	20180902_breast_Drug_TMT10_F24.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030881/20180902_breast_Drug_TMT10_F24.raw	1	24	TMT131	NT=Q Exactive Plus;AC=MS:1002634	NT=Carbamidomethyl;TA=C;MT=fixed;AC=UNIMOD:4	NT=Oxidation;AC=UNIMOD:35;MT=Variable;TA=M	NT=TMT6plex;TA=K;MT=Fixed;AC=UNIMOD:737	NT=TMT6plex;PP=Any N-term;MT=Fixed;AC=UNIMOD:737	AC=MS:1001251;NT=Trypsin	NT=HCD;AC=PRIDE:0000590	32% NCE	10 ppm	20 ppm	breast cancer
